Related Experiment Videos
Impaired human ovarian follicular fluid complement function in hereditary angioedema
R Perricone1, C De Carolis, F Giacomello
1Department of Allergy and Clinical Immunology, University of Rome Tor Vergata, Italy.
Scandinavian Journal of Immunology
|January 13, 2000
Summary
Active complement in human ovarian follicular fluid is essential for ovulation. Hereditary angioedema patients exhibit complement dysfunction and ovarian abnormalities, suggesting a link between complement and ovarian function.
Area of Science:
- Immunology
- Reproductive Biology
- Human Physiology
Background:
- Complement system plays a role in ovulation.
- Hereditary angioedema (HAE) is associated with complement dysfunction and ovarian abnormalities.
- Understanding complement's role in ovarian function is crucial.
Purpose of the Study:
- To investigate complement activity in human ovarian follicular fluid.
- To compare complement function in follicular fluid of healthy women and HAE patients.
- To explore the relationship between complement dysfunction and ovarian abnormalities in HAE.
Main Methods:
- Assessed functional complement activities (total hemolytic complement, classical and alternative pathways, C1 inhibitor) in follicular fluid and serum.
- Quantified complement components (C1 inhibitor, C4, C3, Factor B).
- Clinical evaluation of ovarian morphology and response to danazol treatment.
Main Results:
- Healthy women possess active complement in follicular fluid within normal serum ranges.
- HAE patients show significantly reduced classical pathway activity and undetectable C1 inhibitor in follicular fluid.
- HAE patients exhibit similar complement profiles in serum and follicular fluid, with ovarian abnormalities that improve with danazol treatment.
Conclusions:
- Active complement in follicular fluid is vital for ovulation.
- Complement dysfunction in HAE patients is linked to ovarian abnormalities.
- Danazol treatment in HAE patients normalizes ovarian morphology and improves complement function, suggesting a therapeutic link.